HELX
Franklin Genomic Advancements ETF Equity
Franklin Templeton
·Est. 2020
·US
·
franklintempleton.com/investments/options/exchange-traded-funds/products/29097/SINGLCLASS/franklin-genomic-advancements-etf/HELX
·
← All ETFs
$33.58
-2.56%
(-0.88)
AUM $22.1M
Expense 50.00%
52w Low $24.94
65.3% of range
52w High $38.17
50d MA $33.31
200d MA $33.52
NAV
$33.96
AUM
$22.1M
Expense
50.00%
Holdings
63
Avg Volume
3K
Inception
Feb 25, 2020
Issuer
Franklin Templeton
Exchange
—
Domicile
US
ISIN
US35473P5200
50d MA
$33.31
200d MA
$33.52
About
The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of …
Sector Exposure
Healthcare
96.5%
Basic Materials
2.8%
Technology
0.7%